期刊文献+

临床试验中病人获益的评估——应该由医生还是由病人评估?这重要吗?

Assessing patients' improvement in clinical trials --Should the doctor or patient judge improvement and does it matter?
原文传递
导出
摘要 医生需要从病人的角度理解新疗法的获益,因为他们必须判断向病人提供这些疗法的相对风险和获益。健康状况评价应满足这种需求。目前已开发出了数种有效、可靠、对治疗敏感的由病人完成的测评工具。这些工具为了解某种治疗对预后的影响提供了宝贵线索,例如对功能和生活质量等的影响。对病人而言,功能和生活质量可能比单纯生存更为重要。然而,对某些情况,目前尚无测量特定疾病健康状况的指标,此时则需进行临床变化的整体评估。
出处 《英国医学杂志中文版》 2008年第5期264-265,共2页 The BMJ Chinese Edition
  • 相关文献

参考文献12

  • 1Guyatt GH, Feeny DH, Patrick DL Measuring health-related quality of life. Ann Intern Med 1993;118:622-9.
  • 2Lewis EF, Johnson PA, Johnson W, Collins C, Griffin L, Stevenson LW. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant 2001 ;20:1016-24.
  • 3Spertus J. Selecting end points in clinical trials: what evidence do we really need to evaluate a new treatment? Am Heart J 2001 ;142:745-7.
  • 4Tsevat J, Dawson NV, Wu AW, Lynn J, Soukup JR, Cook EF, et al. Health values of hospitalized patients 80 years or older. HELP Investigators. Hospitalized elderly longitudinal project. JAMA 1998 ;279:371-5.
  • 5Jaes-chke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-15.
  • 6Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994 ;47:81-7.
  • 7Evangelou E, Tsianos G, loannidis JPA. Doctors' versus patients' global assessments of treatment effectiveness : empirical survey of diverse treatments in clinical trials. BMJ 2008 ; doi : 10. 1136/bmj. 39560. 759572. BE.
  • 8Goldman L, Cook EF, Mitchell N, Harley M, Sherman H, Cohn PF. Pitfalls in the serial assessment of cardiac functional status. How a reduction in "ordinary" activity may reduce the apparent degree of cardiac compromise and give a misleading impression of improvement. J Chronic Dis 1982 ;35:763-71.
  • 9Raphael C, Bfiscoe C, Davies J, lan Whinnett Z, Manisty C, Sutton R, et al. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 2007 ;93:476- 82.
  • 10Burkhoff D, Schmidt S, Schulman SP, Myers J, Resar J, Becker LG, et al. Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina treatments-lasers and normal therapies in comparison. Lancet 1999;354:885-90.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部